Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,753–2,760 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Mereo BioPharma Group plc Alvelestat - (ASTRAEUS) Severe alpha-1 antitrypsin deficiency (AATD) Phase 2 Data Released Oral Genetic Disorder
Merrimack Pharmaceuticals Inc. MM-121 SHERLOC Cancer - Heregulin Positive Non-Small Cell Lung Cancer Phase 2 intravenous Oncology
Merrimack Pharmaceuticals Inc. MM-302 HERMIONE Cancer - HER2-positive locally advanced or metastatic breast cancer Phase 2 Intravenous Oncology
Merrimack Pharmaceuticals Inc. MM-141 - CARRIE Cancer - front line pancreatic cancer Phase 2 intravenous Oncology
Merrimack Pharmaceuticals Inc. MM-121 (SHERBOC) HER2 negative metastatic breast cancer Phase 2 Intravenous Oncology
Merrimack Pharmaceuticals Inc. MM-121 (SHERBOC) HER2 negative metastatic breast cancer Phase 2 Intravenous Oncology
Merus N.V. MCLA-129 - (ZENO) Solid Tumors, MET ex14 NSCLC Phase 3 Data Released Intravenous Oncology
Merus N.V. MCLA-129 - (ZENO) Solid Tumors, MET ex14 NSCLC Phase 3 Data Released Intravenous Oncology